Hipertensión arterial: etiopatogenia, clínica, historia natural, complicaciones y tratamiento. Hipertensión arterial en el anciano y en el embarazo

A. Ruiz-Saavedra , J. García-Pérez-Velasco , J.A. Serpa-Morán , C. Tejada-González , A. Leandro-Barros , A. García-Lledó
{"title":"Hipertensión arterial: etiopatogenia, clínica, historia natural, complicaciones y tratamiento. Hipertensión arterial en el anciano y en el embarazo","authors":"A. Ruiz-Saavedra ,&nbsp;J. García-Pérez-Velasco ,&nbsp;J.A. Serpa-Morán ,&nbsp;C. Tejada-González ,&nbsp;A. Leandro-Barros ,&nbsp;A. García-Lledó","doi":"10.1016/j.med.2025.08.013","DOIUrl":null,"url":null,"abstract":"<div><div>Hypertension (HT) is a complex disease characterized by a persistent increase in blood pressure associated with an increased risk of certain complications and premature death. This update provides an analysis of the fundamental concepts related to HT, including its etiology, etiopathogenic mechanisms, clinical manifestations, natural history of the disease, associated complications, and treatment strategies, with a particular focus on vulnerable groups such as older adults and pregnant people. In addition, risk factors and cardiovascular risk modifiers are studied. The importance of detecting resistant and secondary hypertension is emphasized as well as the effect of lifestyle habits and comorbidities on disease progression. Treatment includes, among other measures, lifestyle modifications, following a Mediterranean diet, reducing sodium intake, weight control, regular exercise, and a personalized pharmacological approach that combines angiotensin-converting enzyme inhibitors (ACE inhibitors), angiotensin II receptor blockers (ARBs), calcium channel blockers, and diuretics. New strategies such as renal denervation and the use of innovative agents such as GLP-1 receptor agonists and aldosterone synthase inhibitors are discussed.</div></div>","PeriodicalId":100912,"journal":{"name":"Medicine - Programa de Formación Médica Continuada Acreditado","volume":"14 39","pages":"Pages 2385-2399"},"PeriodicalIF":0.0000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine - Programa de Formación Médica Continuada Acreditado","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0304541225002136","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Hypertension (HT) is a complex disease characterized by a persistent increase in blood pressure associated with an increased risk of certain complications and premature death. This update provides an analysis of the fundamental concepts related to HT, including its etiology, etiopathogenic mechanisms, clinical manifestations, natural history of the disease, associated complications, and treatment strategies, with a particular focus on vulnerable groups such as older adults and pregnant people. In addition, risk factors and cardiovascular risk modifiers are studied. The importance of detecting resistant and secondary hypertension is emphasized as well as the effect of lifestyle habits and comorbidities on disease progression. Treatment includes, among other measures, lifestyle modifications, following a Mediterranean diet, reducing sodium intake, weight control, regular exercise, and a personalized pharmacological approach that combines angiotensin-converting enzyme inhibitors (ACE inhibitors), angiotensin II receptor blockers (ARBs), calcium channel blockers, and diuretics. New strategies such as renal denervation and the use of innovative agents such as GLP-1 receptor agonists and aldosterone synthase inhibitors are discussed.
高血压:病因、临床、自然史、并发症和治疗。老年人和孕妇的高血压
高血压(HT)是一种复杂的疾病,其特征是血压持续升高,与某些并发症和过早死亡的风险增加有关。本更新提供了与HT相关的基本概念的分析,包括其病因、发病机制、临床表现、疾病的自然史、相关并发症和治疗策略,并特别关注老年人和孕妇等弱势群体。此外,还研究了危险因素和心血管危险调节剂。强调了检测顽固性和继发性高血压的重要性,以及生活习惯和合并症对疾病进展的影响。治疗包括改变生活方式,遵循地中海饮食,减少钠摄入量,控制体重,定期锻炼,以及结合血管紧张素转换酶抑制剂(ACE抑制剂),血管紧张素II受体阻滞剂(ARBs),钙通道阻滞剂和利尿剂的个性化药理学方法。新的策略,如肾去神经支配和使用创新的药物,如GLP-1受体激动剂和醛固酮合成酶抑制剂进行了讨论。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.30
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信